Connor Clark & Lunn Investment Management Ltd. Purchases New Stake in Definitive Healthcare Corp. (NASDAQ:DH)

Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Definitive Healthcare Corp. (NASDAQ:DH) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 114,552 shares of the company’s stock, valued at approximately $512,000. Connor Clark & Lunn Investment Management Ltd. owned 0.10% of Definitive Healthcare at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Victory Capital Management Inc. boosted its stake in shares of Definitive Healthcare by 6.5% during the 3rd quarter. Victory Capital Management Inc. now owns 542,170 shares of the company’s stock valued at $2,424,000 after buying an additional 33,161 shares during the period. Hennion & Walsh Asset Management Inc. raised its holdings in shares of Definitive Healthcare by 62.6% during the third quarter. Hennion & Walsh Asset Management Inc. now owns 37,940 shares of the company’s stock worth $170,000 after acquiring an additional 14,609 shares in the last quarter. Bleakley Financial Group LLC acquired a new stake in Definitive Healthcare during the third quarter valued at $74,000. SG Americas Securities LLC purchased a new position in Definitive Healthcare in the third quarter valued at about $84,000. Finally, Sanctuary Advisors LLC acquired a new position in Definitive Healthcare in the 2nd quarter worth about $85,000. Hedge funds and other institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Stock Performance

Shares of NASDAQ DH opened at $4.73 on Friday. The firm has a market capitalization of $546.41 million, a price-to-earnings ratio of -1.53, a PEG ratio of 3.44 and a beta of 1.33. Definitive Healthcare Corp. has a one year low of $3.19 and a one year high of $10.62. The business has a fifty day simple moving average of $4.35 and a 200 day simple moving average of $4.79. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33.

Analyst Upgrades and Downgrades

DH has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Definitive Healthcare from $7.00 to $5.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a research report on Friday, November 8th. Barclays cut their target price on Definitive Healthcare from $6.00 to $4.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 7th. BTIG Research started coverage on Definitive Healthcare in a research note on Tuesday, September 17th. They set a “buy” rating and a $7.00 price target for the company. Finally, Morgan Stanley cut their price objective on Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating on the stock in a research note on Tuesday, August 6th. One analyst has rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $5.81.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.